C
LXRX icon

Covestor’s Lexicon Pharmaceuticals LXRX Stock Holding History

Covestor’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
81
– – ﹤0.01% 2685
2026
Q1 		$0 Hold
81
– – ﹤0.01% 2559
2025
Q4 		$0 Hold
81
– – ﹤0.01% 2527
2025
Q3 		$0 Hold
81
– – ﹤0.01% 2543
2025
Q2 		$0 Hold
81
– – ﹤0.01% 2508
2025
Q1 		$0 Hold
81
– – ﹤0.01% 2507
2024
Q4 		$0 Buy
81
+15
+23% +$18 ﹤0.01% 2516
2024
Q3 		$0 Hold
66
– – ﹤0.01% 2508
2024
Q2 		$0 Hold
66
– – ﹤0.01% 2525
2024
Q1 		$0 Hold
66
– – ﹤0.01% 2523
2023
Q4 		$0 Sell
66
-8,319
-99% -$9.89K ﹤0.01% 2462
2023
Q3 		$9K Hold
8,385
– – 0.01% 1487
2023
Q2 		$19K Buy
+8,385
New +$22.3K 0.01% 1160

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Covestor's LXRX Position: Q2 2026 in Review

Covestor held its Lexicon Pharmaceuticals (LXRX) position steady in Q2 2026 at 81 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

Covestor first reported a position in LXRX in Q2 2023 and has held it in 13 quarters since. The position peaked at $19K in Q2 2023. 148 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Covestor held 81 shares of Lexicon Pharmaceuticals worth $0 as of Q2 2026.
  • Covestor left its Lexicon Pharmaceuticals share count unchanged in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2685 holding.
  • Covestor first reported a position in Lexicon Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Covestor's Lexicon Pharmaceuticals position peaked at $19K in Q2 2023.
  • 148 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.